Treating Cancer with Bispecific Antibodies: Current Status and Future Directions
Treating Cancer with Bispecific Antibodies: Current Status and Future Directions is organized by Horizon CME.
Course opens: 09/08/2023
Course expires: 09/08/2024
Description:
The development of bispecific antibodies opened a new avenue of therapeutic options in oncology. During this webcast, participants will review the current role of bispecific antibodies in treating patients diagnosed with cancer, as well as management strategies for cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome.
Learning Objectives:
• Discuss the current indications of bispecific antibodies in oncology
• Identify new and emerging clinical data regarding the role of bispecific antibodies in cancer treatment
• Review the pharmacology and clinical challenges related to the use of bispecific antibodies
• Describe management strategies for cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome in the context of bispecific antibodies therapy
Additional details will be posted as soon as information is available.